NCBI PubMed Centralopen access
Molecular reprogramming in cutaneous melanoma: the central role of G9a and EZH2 methyltransferase inhibitors in tumor plasticity, immune evasion, and therapeutic resistance.
distributed systems architecture
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 1001159
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.